In ovarian and endometrial carcinoma cells (ARK2, TOV112D), inhibition of LSD1, using siRNA or SP2509, increased ATG7, P62/SQSTM1, and LC3B-II levels and induced GFP-LC3B vesicle formation [75]. The gene discussed is MAP1LC3B; the disease is endometrial carcinoma.